248 related articles for article (PubMed ID: 23374155)
21. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C
Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983
[TBL] [Abstract][Full Text] [Related]
22. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
23. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.
Huang Y; Li X; Muyan M
Endocrine; 2011 Feb; 39(1):48-61. PubMed ID: 21069581
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
27. Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.
Kousidou OCh; Berdiaki A; Kletsas D; Zafiropoulos A; Theocharis AD; Tzanakakis GN; Karamanos NK
Mol Oncol; 2008 Oct; 2(3):223-32. PubMed ID: 19383343
[TBL] [Abstract][Full Text] [Related]
28. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
29. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory modulation of human estrogen receptor α and β activities by dicyclohexyl phthalate in human breast cancer cell lines.
Okazaki H; Takeda S; Matsuo S; Matsumoto M; Furuta E; Kohro-Ikeda E; Aramaki H
J Toxicol Sci; 2017; 42(4):417-425. PubMed ID: 28717100
[TBL] [Abstract][Full Text] [Related]
31. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
32. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
33. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
[TBL] [Abstract][Full Text] [Related]
34. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells.
Stephen RL; Shaw LE; Larsen C; Corcoran D; Darbre PD
J Biol Chem; 2001 Oct; 276(43):40080-6. PubMed ID: 11457860
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor is required for estradiol-stimulated bovine satellite cell proliferation.
Reiter BC; Kamanga-Sollo E; Pampusch MS; White ME; Dayton WR
Domest Anim Endocrinol; 2014 Jul; 48():48-55. PubMed ID: 24906928
[TBL] [Abstract][Full Text] [Related]
37. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
38. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
39. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
40. Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
Samanta S; Sharma VM; Khan A; Mercurio AM
Oncogene; 2012 Nov; 31(44):4689-97. PubMed ID: 22266872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
